104685-75-8

Basic information

• Product Name: methyl 6-amino-5-nitropyridine-3-carboxylate
• Synonyms: 6-AMino-5-nitro-nicotinic acid Methyl ester;Methyl 6-aMino-5-nitropyridazine-3-carboxylate;methyl 6-amino-5-nitronicotinate;methyl 6-amino-5-nitropyridine-3-carboxylate;6-AMINO-5-NITROPYRIDINE-3-CARBOXYLIC ACID METHYL ESTER
• CAS NO: 104685-75-8
• Molecular Formula: C₇H₇N₃O₄
• Molecular Weight: 197.149
• Mol File: 104685-75-8.mol

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C
• CAS DataBase Reference: methyl 6-amino-5-nitropyridine-3-carboxylate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 6-amino-5-nitropyridine-3-carboxylate(104685-75-8)
• EPA Substance Registry System: methyl 6-amino-5-nitropyridine-3-carboxylate(104685-75-8)

Safety Data

• Hazardous Substances Data: 104685-75-8(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Methyl 6-amino-5-nitropyridine-3-carboxylate is used as a synthetic intermediate for the preparation of annulated nitrogen heterocycles, which are important in the development of pharmaceutical compounds with various therapeutic applications. The presence of the nitro and amino groups allows for further chemical modifications, enabling the synthesis of a wide range of bioactive molecules.
Used in Organic Synthesis:
In the field of organic synthesis, methyl 6-amino-5-nitropyridine-3-carboxylate serves as a key building block for the creation of complex organic molecules. Its unique structure and functional groups facilitate multiple reaction pathways, making it a valuable component in the synthesis of various organic compounds, including potential pharmaceuticals, agrochemicals, and other specialty chemicals.
Used in Research and Development:
Methyl 6-amino-5-nitropyridine-3-carboxylate is also utilized in research and development settings, where it can be employed to explore new chemical reactions, investigate the properties of novel compounds, and develop innovative synthetic methodologies. Its reactivity and structural features make it an interesting subject for academic and industrial research, potentially leading to new discoveries and applications.

Upstream product

• 6635-31-0 6-hydroxy-5-nitronicotinic acid 
• 59237-53-5 methyl 6-chloro-5-nitro-pyridine-3-carboxylate 
• 89488-06-2 5-nitro-6-aminonicotinic acid 
• 144-55-8 sodium hydrogencarbonate 

Downstream Products

• 104685-76-9 5,6-diamino-nicotinic acid methyl ester 
• 77862-95-4 methyl 3H-imidazo[4,5-b]pyridine-6-carboxylate 
• 1260385-82-7 1H-[1,2,3]triazolo[4,5-b]pyridine-6-carboxylic acid 

Relevant articles and documents

Novel indanyl-substituted imidazo[1,2-a]pyridines as potent reversible inhibitors of the gastric H+/K+-ATPase

A series of novel 8-indanylamino- and 8-indanyloxy-substituted imidazo[1,2-a]pyridines with reduced lipophilicity was synthesized from easily accessible starting compounds. The anti-secretory activity of these compounds has been assessed in a competitive

BICYCLIC HYDROXAMIC ACIDS USEFUL AS INHIBITORS OF MAMMALIAN HISTONE DEACETYLASE ACTIVITY

A compound of formula (Ia) or (Ib) or a pharmaceutically acceptable salt thereof. The compound is an inhibitor of a histone deacetylase, and as such is useful in terepy, e.g. in the treatment of autoimmune disorders, mental disorders, neurodegenerative disorders, and hyperproliferative disorders.

Phenyl-aza-benzimidazole compounds for modulating IgE and inhibiting cellular proliferation

The present invention is directed to small molecule inhibitors of the IgE response to allergens, which are useful in the treatment of allergy and/or asthma or any diseases where IgE is pathogenic. This invention also relates to phenyl-aza-benzimidazole molecules that are cellular proliferation inhibitors and thus are useful as anticancer agents. This invention further relates to small molecules which suppress cytokines and leukocytes.

Substituted triazolopyridine compounds

A compound of formula wherein R1 is —NR′R″, wherein R′ and R″ are independently selected from the group consisting of lower alkyl, —(CH2)n—C(O)NRaRb, —(CH2)n-heteroaryl, —(CH2)n-aryl, —(CH2)n—CN, —(CH2)n—O-lower alkyl or —(CH2)n-cycloalkyl, or R′ and R″ form together with the N-atom a five or six-membered non- aromatic ring, containing no or one additional heteroatom selected from the group consiting of O and S, and said ring being unsubstituted or substituted by one or two substituents, selected from the group consisting of lower alkyl, —C(O)NRaRb and —(CH2)n—O-lower alkyl, and RaRb are independently from each other hydrogen or lower alkyl; R2 is aryl or heteroaryl, unsubstituted or substituted by lower alkyl or halogen; and n is 0, 1, 2 or 3; or a pharmaceutically acceptable salt thereof. Compounds of formula I are useful in the treatment of disease associated with the adenosine A2 receptor.

Azaindenes.

The invention concerns azaindenes of the formula I (and their physiologically acceptable salts), together with pharmaceutical compositions containing them. The azaindenes antagonise the actions of angiotensin II and are of value in treating conditions suc

Benzimidazolyl-thio-tetrahydroquinolines and anti-peptic ulcer compositions containing the same

Novel tetrahydroquinoline derivatives and salts thereof and novel imidazopyridine derivatives and salts thereof, both having excellent anti-peptic ulcer activities, and are useful as treating agents for peptic ulcers such as gastric ulcer, duodenum ulcer and the like.